IP Library Granted Patent US 10,798,962
Granted Patent B2
US 10,798,962 · App. 15/538,825 · Granted Oct 13, 2020

Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids

Inventors: Günter Knaup (Bruchkoebel, DE); Milan Latinovic (Nidda, DE); Michael Schwarm (Alzenau, DE)
Assignee: Evonik Operations GmbH
A23L33/12A23D9/02A23L5/30A23L33/115A23L33/18A61K9/16A61K31/202A61K47/183A61K2300/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,798,962
App. No.
15/538,825
Granted
Oct 13, 2020
Kind
B2
Abstract

A process for increasing the stability of a composition containing a polyunsaturated omega-3 fatty acid against oxidation proceeds by (i) providing a starting composition containing at least one polyunsaturated omega-3 fatty acid component; (ii) providing a lysine composition; (iii) admixing an aqueous, an aqueous-alcoholic or an alcoholic solution of starting composition and lysine composition, and subjecting resulting admixture to spray drying conditions subsequently, thus forming a solid product composition containing at least one salt of a cation derived from lysine with an anion derived from a polyunsaturated omega-3 fatty acid; the product composition exhibiting a solvent content SC selected from the following: SC<5 wt %, SC<3 wt %, SC<1 wt %, or SC<0.5 wt %.

Claims (17)

1. A process for increasing the stability towards oxidation of a composition comprising a polyunsaturated omega-3 fatty acid, said process comprising:

(i) providing a starting composition comprising at least one polyunsaturated omega-3 fatty acid component;

(ii) providing a lysine composition;

(iii) admixing an aqueous, an aqueous-alcoholic or an alcoholic solution of starting composition and lysine composition, and subjecting a resulting admixture to spray drying conditions subsequently, thus forming a solid product composition comprising at least one salt of a cation derived from lysine with an anion derived from a polyunsaturated omega-3 fatty acid; the product composition exhibiting a solvent content of less than 5 wt %,

wherein at least 90 wt % of the product composition consists of one or more salts of cations derived from lysine with anions derived from one or more polyunsaturated omega-3 fatty acids and other naturally occurring fatty acids.

2. The process according to claim 1 , wherein lysine composition in (ii) is provided in such a manner that the ratio R=n(ca)/n(lys) of the amount of carboxylic acid functions n(ca) in the starting composition provided in (i) and the amount of lysine n(lys) in the lysine composition provided in (ii) is in a range of 0.9<R<1.1.

3. The process according to claim 1 , wherein the starting composition provided in (i) does not contain more than 5 wt % fatty acid esters.

4. The process according to claim 1 , wherein starting composition in (i) and lysine composition in (ii) are provided in such a manner that at least 95 wt % of the product composition consists of one or more salts of cations derived from lysine with anions derived from one or more polyunsaturated omega-3 fatty acids and other naturally occurring fatty acids.

5. The process according to claim 1 , wherein said starting composition is a food product comprising a polyunsaturated omega-3 fatty acid.

6. The process according to claim 1 , wherein said starting composition is a nutritional product comprising a polyunsaturated omega-3 fatty acid.

7. The process according to claim 1 , wherein said starting composition is a pharmaceutical product comprising a polyunsaturated omega-3 fatty acid.

8. The process according to claim 1 , wherein the product composition has a solvent content of less than 3 wt %.

9. The process according to claim 1 , wherein lysine composition in (ii) is provided in such a manner that the ratio R=n(ca)/n(lys) of the amount of carboxylic acid functions n(ca) in the starting composition provided in (i) and the amount of lysine n(lys) in the lysine composition provided in (ii) is in a range of 0.95<R<1.05.

10. The process according to claim 1 , wherein the starting composition provided in (i) does not contain more than 3 wt % fatty acid esters.

11. The process according to claim 1 , wherein at least 97 wt % of the product composition consists of one or more salts of cations derived from lysine with anions derived from one or more polyunsaturated omega-3 fatty acids and other naturally occurring fatty acids.

12. The process according to claim 1 , wherein increasing the stability towards oxidation of the composition does not comprise microencapsulation.

13. The process according to claim 1 , wherein the product composition is substantially free of antioxidants.

Assignments (2)
CHANGE OF NAME Recorded Nov 18, 2019
From: EVONIK DEGUSSA GMBH
To: EVONIK OPERATIONS GMBH
Reel/Frame 051045/0872 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2017
From: KNAUP, GUENTER; LATINOVIC, MILAN; SCHWARM, MICHAEL
To: EVONIK DEGUSSA GMBH
Reel/Frame 042787/0212 →
Priority Claims (1)
EP 14199989 · Dec 23, 2014 · regional
Continuity (1)
Related Publication 20170360072A1 · Dec 21, 2017